Ironwood Pharmaceuticals to Host First Quarter 2021 Investor Update Call

Rhea-AI Summary

Ironwood Pharmaceuticals (NASDAQ: IRWD) has announced its first quarter 2021 investor update conference call and webcast scheduled for May 6, 2021, at 8:30 a.m. Eastern Time. Interested participants can join by calling (833) 350-1432 for U.S. and Canada, or (647) 689-6932 internationally, using conference ID 8067476. A replay will be available after 11:30 a.m. on the same day until May 20, 2021. Ironwood focuses on developing treatments for gastrointestinal diseases, with linaclotide being a key product for IBS-C and CIC.

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) today announced it will host its first quarter 2021 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thursday, May 6, 2021. Individuals interested in participating in the call should dial (833) 350-1432 (U.S. and Canada) or (647) 689-6932 (international) using conference ID number and event passcode 8067476. To access the webcast, please visit the Investors section of Ironwood’s website at www.ironwoodpharma.com at least 15 minutes prior to the start of the call to ensure adequate time for any software downloads that may be required.

The call will be available for replay via telephone starting Thursday, May 6, 2021 at approximately 11:30 a.m. Eastern Time, running through 11:59 p.m. Eastern Time on May 20, 2021. To listen to the replay, dial (800) 585-8367 (U.S. and Canada) or (416) 621-4642 (international) using conference ID number 8067476. The archived webcast will be available on Ironwood’s website for 14 days beginning approximately one hour after the call has completed.

About Ironwood Pharmaceuticals
Ironwood Pharmaceuticals (Nasdaq: IRWD) is a GI-focused healthcare company dedicated to creating medicines that make a difference for patients living with GI diseases. We discovered, developed and are commercializing linaclotide, the U.S. branded prescription market leader for adults with irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC).

Ironwood was founded in 1998 and is headquartered in Boston, Mass. For more information, please visit our website at www.ironwoodpharma.com or www.twitter.com/ironwoodpharma; information that may be important to investors will be routinely posted in both these locations.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210422005103/en/

FAQ

When is Ironwood Pharmaceuticals' first quarter 2021 investor update conference call?

Ironwood Pharmaceuticals' first quarter 2021 investor update conference call is scheduled for May 6, 2021, at 8:30 a.m. Eastern Time.

How can I participate in the Ironwood Pharmaceuticals conference call?

To participate in the Ironwood Pharmaceuticals conference call, dial (833) 350-1432 for U.S. and Canada or (647) 689-6932 internationally and use conference ID 8067476.

What is the replay period for Ironwood Pharmaceuticals' conference call?

The replay for Ironwood Pharmaceuticals' conference call will be available from May 6, 2021, at 11:30 a.m. until May 20, 2021.

What is Ironwood Pharmaceuticals known for?

Ironwood Pharmaceuticals is known for developing GI-focused treatments, particularly linaclotide for irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC).

Where can I find more information about Ironwood Pharmaceuticals?

More information about Ironwood Pharmaceuticals can be found on their official website at www.ironwoodpharma.com.